Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
angeles willett[Author]
(66 results)?
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
J Natl Cancer Inst. 2023 Aug 8;115(8):994-997. doi: 10.1093/jnci/djad095.
J Natl Cancer Inst. 2023.
PMID: 37202363
Free PMC article.
Clinical Trial.
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.
Hornstein NJ, Zeineddine MA, Gunes BB, Pellatt AJ, Knafl M, Zhu H, Willett AF, Yousef A, Liu S, Sun R, Futreal A, Woodman SE, Taggart MW, Overman MJ, Halperin DM, Raghav KP, Shen JP.
Hornstein NJ, et al. Among authors: willett af.
Cancer Res Commun. 2024 May 29;4(5):1363-1368. doi: 10.1158/2767-9764.CRC-24-0019.
Cancer Res Commun. 2024.
PMID: 38709066
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial.
Raghav KP, Stephen B, Karp DD, Piha-Paul SA, Hong DS, Jain D, Chudy Onwugaje DO, Abonofal A, Willett AF, Overman M, Smaglo B, Huey RW, Meric-Bernstam F, Varadhachary GR, Naing A.
Raghav KP, et al. Among authors: willett af.
J Immunother Cancer. 2022 May;10(5):e004822. doi: 10.1136/jitc-2022-004822.
J Immunother Cancer. 2022.
PMID: 35618285
Free PMC article.
Clinical Trial.
Item in Clipboard
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary.
Raghav K, Hwang H, Jácome AA, Bhang E, Willett A, Huey RW, Dhillon NP, Modha J, Smaglo B, Matamoros A Jr, Estrella JS, Jao J, Overman MJ, Wang X, Greco FA, Loree JM, Varadhachary GR.
Raghav K, et al. Among authors: willett a.
Clin Cancer Res. 2021 Jun 15;27(12):3414-3421. doi: 10.1158/1078-0432.CCR-20-4117. Epub 2021 Apr 15.
Clin Cancer Res. 2021.
PMID: 33858857
Free PMC article.
Item in Clipboard
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.
Raghav K, Liu S, Overman MJ, Willett AF, Knafl M, Fu SC, Malpica A, Prasad S, Royal RE, Scally CP, Mansfield PF, Wistuba II, Futreal AP, Maru DM, Solis Soto LM, Parra Cuentas ER, Chen H, Villalobos P, Verma A, Mahvash A, Hwu P, Cortazar P, McKenna E, Yun C, Dervin S, Schulze K, Darbonne WC, Morani AC, Kopetz S, Fournier KF, Woodman SE, Yao JC, Varadhachary GR, Halperin DM.
Raghav K, et al. Among authors: willett af.
Cancer Discov. 2021 Nov;11(11):2738-2747. doi: 10.1158/2159-8290.CD-21-0331. Epub 2021 Jul 14.
Cancer Discov. 2021.
PMID: 34261675
Free PMC article.
Item in Clipboard
Cite
Cite